Harvard Apparatus Regenerative Technology Inc
OTC:HRGN
Harvard Apparatus Regenerative Technology Inc
OTC:HRGN
Price:
1.572
USD
Market Closed
Market Cap:
$27m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Harvard Apparatus Regenerative Technology Inc
OTC:HRGN
|
US |
|
H
|
Hydrogene De France SA
F:9QW
|
FR |
|
K
|
Kao Corp
XBER:KAO
|
JP |
|
T
|
Trivium Real Estate Socimi SA
MAD:YTRI
|
ES |
|
Q
|
Quantum Healthcare Ltd
SGX:V8Y
|
SG |
Balance Sheet
Balance Sheet Decomposition
Harvard Apparatus Regenerative Technology Inc
Harvard Apparatus Regenerative Technology Inc
Balance Sheet Decomposition is not available for
Harvard Apparatus Regenerative Technology Inc
Harvard Apparatus Regenerative Technology Inc
Balance Sheet
Harvard Apparatus Regenerative Technology Inc
Harvard Apparatus Regenerative Technology Inc
Currency: USD
| Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Cash Equivalents |
1
|
1
|
1
|
0
|
2
|
1
|
|
| Cash |
1
|
1
|
1
|
0
|
2
|
1
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
1
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
2
|
2
|
2
|
1
|
3
|
2
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
2
|
3
|
1
|
1
|
1
|
1
|
|
| Other Long-Term Assets |
0
|
0
|
1
|
2
|
1
|
1
|
|
| Total Assets |
2
N/A
|
2
-10%
|
2
+29%
|
3
+9%
|
4
+70%
|
3
-40%
|
|
| Liabilities | |||||||
| Accounts Payable |
0
|
1
|
1
|
0
|
0
|
0
|
|
| Accrued Liabilities |
0
|
4
|
1
|
1
|
0
|
1
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
1
|
5
|
1
|
1
|
1
|
2
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
1
N/A
|
5
+415%
|
1
-71%
|
1
-31%
|
1
+26%
|
2
+33%
|
|
| Equity | |||||||
| Common Stock |
0
|
0
|
4
|
0
|
0
|
0
|
|
| Retained Earnings |
69
|
77
|
83
|
92
|
100
|
107
|
|
| Additional Paid In Capital |
70
|
74
|
80
|
93
|
103
|
107
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
1
N/A
|
3
N/A
|
1
N/A
|
2
+66%
|
3
+96%
|
1
-67%
|
|
| Total Liabilities & Equity |
2
N/A
|
2
-10%
|
2
+29%
|
3
+9%
|
4
+70%
|
3
-40%
|
|
| Shares Outstanding | |||||||
| Common Shares Outstanding |
9
|
11
|
12
|
14
|
16
|
18
|
|
| Preferred Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
|
Switch to:
Switch to:
See Also
Discover More
